Quanta Computer Inc. - 2382.TW

2382.TW Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2382.TW	0.2	-7.0	-5.1	-15.1	-12.3	8.5	178.9	300.8	235.3	266.7
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 2382.TW with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2382.TW
name	Quanta Computer Inc.
price	260.5
changes percentage	0.1923
change	0.5
day low	259
day high	263.5
year high	345
year low	225.5
market cap	1004102720500
price avg 50	291.27
price avg 200	283.89
exchange	TAI
volume	23118600
avg volume	22759250
open	261
previous close	260
eps	13.96
pe	18.66
earnings announcement	2025-03-13T10:59:00.000+0000
shares outstanding	3854521000
timestamp	2025-01-17 05:30:04

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 59.7%

Overall Quarterly Financial Health: 60.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	1085611052000	1280429312000	-15.22
gross profit	84882959000	70915012000	19.70
gross profit ratio	0.08	0.06	41.18
research and development expenses	23293587000	21336340000	9.17
operating expenses	84882959000	39725427000	113.67
interest income	10620242000	5018167000	111.64
interest expense	8915024000	4370078000	104.00
ebitda	72127280000	55248981000	30.55
ebitdaratio	0.07	0.04	53.98
operating income	43549597000	45146005000	-3.54
operating income ratio	0.04	0.04	13.77
net income	39676394000	28957466000	37.02
net income ratio	0.04	0.02	61.60
eps	10.29	7.51	37.02

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,085,611 million in 2023 from 1,280,429 million in 2022 representing a change of -15.22%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 84,883 million in 2023 from 39,725 million in 2022 representing a change of 113.67%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 43,550 million in 2023 from 45,146 million in 2022 representing a change of -3.54%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 84,883 million in 2023 from 70,915 million in 2022 representing a change of 19.7%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 23,294 million in 2023 from 21,336 million in 2022 representing a change of 9.17%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 72,127 million in 2023 from 55,249 million in 2022 representing a change of 30.55%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 39,676 million in 2023 from 28,957 million in 2022 representing a change of 37.02%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 10.29 in 2023 from 10.29 in 2022 representing a change of 37.02%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	424549240000	309954132000	36.97
gross profit	31124796000	26232150000	18.65
gross profit ratio	0.07	0.08	-13.38
research and development expenses	6800953000	6284655000	8.22
operating expenses	31124796000	11400613000	173.01
interest income	1740050000	3046847000	-42.89
interest expense	1980403000	1650620000	19.98
ebitda	26160288000	18142068000	44.20
ebitdaratio	0.06	0.06	5.27
operating income	0	15208031000	-100.00
operating income ratio	0	0.05	-100.00
net income	16633121000	15128243000	9.95
net income ratio	0.04	0.05	-19.73
eps	4.32	3.92	10.20

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 424,549 million in 2024Q3 from 309,954 million in 2024Q2 representing a change of 36.97%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 31,125 million in 2024Q3 from 26,232 million in 2024Q2 representing a change of 18.65%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 6,801 million in 2024Q3 from 6,285 million in 2024Q2 representing a change of 8.22%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 26,160 million in 2024Q3 from 18,142 million in 2024Q2 representing a change of 44.2%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 16,633 million in 2024Q3 from 15,128 million in 2024Q2 representing a change of 9.95%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.32 in 2024Q3 from 4.32 in 2024Q2 representing a change of 10.2%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 31,125 million in 2024Q3 from 11,401 million in 2024Q2 representing a change of 173.01%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 0 million in 2024Q3 from 15,208 million in 2024Q2 representing a change of -100.0%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	690120045000	816133646000	-15.44
total liabilities	496227719000	639610189000	-22.42
total equity	193892326000	176523457000	9.84
cash and cash equivalents	177234068000	204637294000	-13.39
short term investments	44201587000	13610456000	224.76
long term investments	6224910000	-8549302000	172.81
total current assets	610447590000	733270060000	-16.75
total non current assets	79672455000	82863586000	-3.85
total current liabilities	483012749000	628590767000	-23.16
total non current liabilities	13214970000	11019422000	19.92
common stock	38626274000	38626274000	0.00
retained earnings	135402556000	118762665000	14.01
total debt	167750223000	257984164000	-34.98

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 690,120 million in 2023 from 816,134 million in 2022 representing a change of -15.44%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 177,234 million in 2023 from 204,637 million in 2022 representing a change of -13.39%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 610,448 million in 2023 from 733,270 million in 2022 representing a change of -16.75%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 496,228 million in 2023 from 639,610 million in 2022 representing a change of -22.42%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 193,892 million in 2023 from 176,523 million in 2022 representing a change of 9.84%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 44,202 million in 2023 from 13,610 million in 2022 representing a change of 224.76%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 483,013 million in 2023 from 628,591 million in 2022 representing a change of -23.16%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 135,403 million in 2023 from 118,763 million in 2022 representing a change of 14.01%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 167,750 million in 2023 from 257,984 million in 2022 representing a change of -34.98%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	869826281000	748673814000	16.18
total liabilities	660766481000	555207119000	19.01
total equity	209059800000	193466695000	8.06
cash and cash equivalents	123248286000	144964133000	-14.98
short term investments	28517717000	11045923000	158.17
long term investments	-19950929000	8038358000	-348.20
total current assets	784458161000	663032114000	18.31
total non current assets	85368120000	85641700000	-0.32
total current liabilities	617530527000	539507930000	14.46
total non current liabilities	43235954000	15699188999	175.40
common stock	38626274000	38626274000	0.00
retained earnings	144467586000	127834465000	13.01
total debt	187417832000	144368032000	29.82

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 869,826 million in 2024Q3 from 748,674 million in 2024Q2 representing a change of 16.18%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 209,060 million in 2024Q3 from 193,467 million in 2024Q2 representing a change of 8.06%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 28,518 million in 2024Q3 from 11,046 million in 2024Q2 representing a change of 158.17%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 784,458 million in 2024Q3 from 663,032 million in 2024Q2 representing a change of 18.31%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 144,468 million in 2024Q3 from 127,834 million in 2024Q2 representing a change of 13.01%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 660,766 million in 2024Q3 from 555,207 million in 2024Q2 representing a change of 19.01%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 123,248 million in 2024Q3 from 144,964 million in 2024Q2 representing a change of -14.98%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 617,531 million in 2024Q3 from 539,508 million in 2024Q2 representing a change of 14.46%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 187,418 million in 2024Q3 from 144,368 million in 2024Q2 representing a change of 29.82%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-27403226000	42380227000	-164.66
operating cash flow	124332934000	11415071000	989.20
free cash flow	115060076000	-5890158000	2053.43
capital expenditure	-8832411000	-17305229000	48.96
depreciation and amortization	11436887000	10102976000	13.20
deferred income tax	0	0	NaN
stock based compensation	164000	0	NaN
accounts payables	-47380377000	-55299943000	14.32
inventory	103234130000	-13461465000	866.89
acquisitions net	0	-18994000	100.00
investments in property plant and equipment	-8832411000	-17305229000	48.96
net cash used for investing activites	-37612146000	-14142772000	-165.95
debt repayment	-88660336000	58481146000	-251.60
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-23764557000	-26009039000	8.63
net cash used provided by financing activities	-114205168000	31294633000	-464.94
cash at end of period	177234068000	204637294000	-13.39
accounts receivables	24657929000	5494828000	348.75
cash at beginning of period	204637294000	162257067000	26.12

Overall Score of Annual Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -27,403 million in 2023 from 42,380 million in 2022 representing a change of -164.66%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -8,832 million in 2023 from -17,305 million in 2022 representing a change of 48.96%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 24,658 in 2023 from 5,495 million in 2022 representing a change of 348.75%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 124,333 million in 2023 from 11,415 million in 2022 representing a change of 989.2%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 115,060 million in 2023 from -5,890 million in 2022 representing a change of 2053.43%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 47,380 million in 2023 from 55,300 million in 2022 representing a change of 14.32%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -23,765 million in 2023 from -26,009 million in 2022 representing a change of 8.63%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	-47152671000	-20063974000	-135.01
free cash flow	-49613166000	-23865596000	-107.89
capital expenditure	-2460495000	-3735037000	34.12
depreciation and amortization	2903500000	2934037000	-1.04
deferred income tax	0	0	NaN
stock based compensation	1001000	321000	211.84
accounts receivables	-128082290000	8232636000	-1655.79
accounts payables	0	19600374000	-100.00
inventory	-39218146000	-36476198000	-7.52
acquisitions net	179460000	171136000	4.86
investments in property plant and equipment	-2330233000	-4176077000	44.20
net cash used for investing activites	-19511162000	-316146000	-6071.57
debt repayment	46367820000	-1667477000	2880.72
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	621648000	-35312315000	101.76
net cash used provided by financing activities	45958536000	-37315089000	223.16
net change in cash	-21715847000	-57095631000	61.97
cash at end of period	123248286000	144964133000	-14.98
cash at beginning of period	144964133000	202059764000	-28.26

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -21,716 million in 2024Q3 from -57,096 million in 2024Q2 representing a change of 61.97%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 19,600 million in 2024Q2 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -128,082 million in 2024Q3 from 8,233 million in 2024Q2 representing a change of -1655.79%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 622 million in 2024Q3 from -35,312 million in 2024Q2 representing a change of 101.76%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to -47,153 million in 2024Q3 from -20,064 million in 2024Q2 representing a change of -135.01%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -49,613 million in 2024Q3 from -23,866 million in 2024Q2 representing a change of -107.89%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -2,460 million in 2024Q3 from -3,735 million in 2024Q2 representing a change of 34.12%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 1 million in 2024Q3 from 0 million in 2024Q2 representing a change of 211.84%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	281.65	332.19	-15.22
net income per share	10.29	7.51	37.02
operating cash flow per share	32.26	2.96	989.20
free cash flow per share	29.85	-1.53	2053.43
cash per share	57.45	56.62	1.46
book value per share	50.3	45.8	9.84
tangible book value per share	50.17	45.57	10.10
shareholders equity per share	48.31	43.89	10.08
interest debt per share	45.83	68.06	-32.66
market cap	824867066000	278681723700	195.99
enterprise value	815383221000	332028593700	145.58
pe ratio	20.79	9.62	116.02
price to sales ratio	0.76	0.22	249.11
pocfratio	6.63	24.41	-72.83
pfcf ratio	7.17	-47.31	115.15
pb ratio	4.43	1.65	168.89
ptb ratio	4.43	1.65	168.89
ev to sales	0.75	0.26	189.65
enterprise value over ebitda	11.3	6.01	88.11
ev to operating cash flow	6.56	29.09	-77.45
ev to free cash flow	7.09	-56.37	112.57
earnings yield	0.05	0.1	-53.71
free cash flow yield	0.14	-0.02	759.97
debt to equity	0.9	1.53	-40.93
debt to assets	0.24	0.32	-23.10
net debt to ebitda	-0.13	0.97	-113.62
current ratio	1.26	1.17	8.34
interest coverage	4.88	10.33	-52.71
income quality	3.13	0.28	1019.51
dividend yield	0.03	0.09	-69.13
payout ratio	0.6	0.9	-33.31
sales general and administrative to revenue	0.01	0.01	27.16
research and ddevelopement to revenue	0.02	0.02	28.76
intangibles to total assets	0.0	0.0	-31.22
capex to operating cash flow	0.07	1.52	-95.31
capex to revenue	0.01	0.01	-39.80
capex to depreciation	0.77	1.71	-54.91
stock based compensation to revenue	0.0	0	NaN
graham number	105.78	86.13	22.81
roic	0.09	0.08	23.68
return on tangible assets	0.06	0.04	61.98
graham net net	-4.66	-24.76	81.16
working capital	127434841000	104679293000	21.74
tangible asset value	193386834000	175654380000	10.10
net current asset value	114219871000	93659871000	21.95
invested capital	192579731000	172943025000	11.35
average receivables	271949576500	274555488500	-0.95
average payables	190918177500	221727394500	-13.90
average inventory	174810022500	211226283000	-17.24
days sales outstanding	87.39	80.95	7.94
days payables outstanding	61.39	64.43	-4.72
days of inventory on hand	45.14	68.16	-33.77
receivables turnover	4.18	4.51	-7.36
payables turnover	5.95	5.66	4.95
inventory turnover	8.09	5.36	50.99
roe	0.21	0.17	24.47
capex per share	2.29	4.49	-48.96

• Positive

  ROE: Return on Equity (ROE) increased to 0.21 on 2023-12-31 from 0.17 on 2022-12-31, representing a change of 24.47%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 20.79 on 2023-12-31 from 9.62 on 2022-12-31, representing a change of 116.02%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.26 on 2023-12-31 from 1.17 on 2022-12-31, representing a change of 8.34%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.90 on 2023-12-31 from 1.53 on 2022-12-31, representing a change of -40.93%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
2382.TW
calendar year	2024	2024	NaN
revenue per share	110.27	80.31	37.29
net income per share	4.32	3.92	10.20
operating cash flow per share	-12.25	-5.2	-135.56
free cash flow per share	-12.89	-6.18	-108.37
cash per share	39.42	40.43	-2.49
book value per share	54.3	50.13	8.31
tangible book value per share	54.18	50.02	8.30
shareholders equity per share	52.28	48.18	8.53
interest debt per share	49.19	37.84	30.01
market cap	1016468505624	1190577287035.5	-14.62
enterprise value	1080638051624	1189981186035.5	-9.19
pe ratio	15.28	19.67	-22.35
price to sales ratio	2.39	3.84	-37.67
pocfratio	-21.56	-59.34	63.67
pfcf ratio	-20.49	-49.89	58.93
pb ratio	5.05	6.4	-21.15
ptb ratio	5.05	6.4	-21.15
ev to sales	2.55	3.84	-33.70
enterprise value over ebitda	41.31	65.59	-37.02
ev to operating cash flow	-22.92	-59.31	61.36
ev to free cash flow	-21.78	-49.86	56.32
earnings yield	0.02	0.01	28.78
free cash flow yield	-0.05	-0.02	-143.49
debt to equity	0.93	0.78	19.90
debt to assets	0.22	0.19	11.74
net debt to ebitda	2.45	-0.03	7565.41
current ratio	1.27	1.23	3.37
interest coverage	0	9.21	-100.00
income quality	-2.22	-1.33	-67.10
dividend yield	0.0	0.03	-97.94
payout ratio	0.04	2.33	-98.40
sales general and administrative to revenue	0.01	0.01	-24.74
research and ddevelopement to revenue	0.02	0.02	-20.99
intangibles to total assets	0.0	0.0	-3.51
capex to operating cash flow	-0.05	-0.19	71.97
capex to revenue	0.01	0.01	-51.91
capex to depreciation	0.85	1.27	-33.43
stock based compensation to revenue	0.0	0.0	127.67
graham number	71.29	65.18	9.36
roic	0	0.03	-100.00
return on tangible assets	0.02	0.02	-5.37
graham net net	-103.14	-25.88	-298.49
working capital	166927634000	123524184000	35.14
tangible asset value	208592260000	193049650000	8.05
net current asset value	123691680000	107824995000	14.72
invested capital	235383117000	192926421000	22.01
average receivables	138017220000	280139001500	-50.73
average payables	265787967000	226673585000	17.26
average inventory	204172064500	166327942000	22.75
days sales outstanding	0	80.15	-100.00
days payables outstanding	67.52	74.99	-9.96
days of inventory on hand	51.19	58.55	-12.57
receivables turnover	0	1.12	-100.00
payables turnover	1.33	1.2	11.06
inventory turnover	1.76	1.54	14.37
roe	0.08	0.08	1.55
capex per share	0.64	0.97	-33.97

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 15.28 on 2024-09-30 Q3 from 19.67 on 2024-06-30 Q2, representing a change of -22.35%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.27 on 2024-09-30 Q3 from 1.23 on 2024-06-30 Q2, representing a change of 3.37%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.93 on 2024-09-30 Q3 from 0.78 on 2024-06-30 Q2, representing a change of 19.90%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 263.81 which is higher than current price 260.5, indicates the company may be undervalued.